Great to see some new interest in this stock. Lots of catalysts over the next few months:
- Migraine product comes to market. Should be their biggest product. - Marketing campaign to start - Expanding distribution channels - Expect more reorders after the 1st of the year
I don't think international sales will be in the near term, but am not sure on that.
The stock should get steady increased interest over the next few months.